These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 17487119)

  • 1. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
    Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
    Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
    Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
    Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
    Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
    J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
    Fritchie K; Zedek D; Grenache DG
    Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.
    Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
    Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemic complication in patients with oral squamous cell carcinoma.
    Iwase M; Takemi T; Manabe M; Nagumo M
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
    Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
    Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
    Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
    Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of renal pelvic squamous cell carcinoma accompanied with humoral hypercalcemia of malignancy (HHM)].
    Furukawa M; Tohbu S; Matsuo T; Hayashida Y; Takehara K; Tsuda S; Maeda K; Iwasaki S; Saito Y; Iwasaki K; Nakashima M
    Hinyokika Kiyo; 2005 Apr; 51(4):265-8. PubMed ID: 15912787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy.
    Bolliger AP; Graham PA; Richard V; Rosol TJ; Nachreiner RF; Refsal KR
    Vet Clin Pathol; 2002; 31(1):3-8. PubMed ID: 12019470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
    Body JJ; Dumon JC; Thirion M; Cleeren A
    J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of intraoperative parathyroid hormone does not predict normal postoperative parathyroid hormone levels.
    Starr FL; DeCresce R; Prinz RA
    Surgery; 2000 Dec; 128(6):930-5;discussion 935-6. PubMed ID: 11114626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH-independent hypercalcaemia and non-melanoma skin cancer.
    Nicolae I; Schipor S
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):449-52. PubMed ID: 19778357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
    Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
    N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
    Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
    J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.